Medicenna Therapeutics Corp opened trading today at $2.84 and closed at $2.62. prices ranged from $2.62 to $2.89.

Shares eased -7.09% from the previous day's close of $2.82.

During the day across North America, the TSX Composite closed -0.14% at 22259.16, the S&P 500 closed 0.13% at 5187.70, the Dow Jones Industrial Average closed 0.08% at 38884.26 and the Nasdaq Composite closed -0.10% at 16332.56.

Medicenna Therapeutics Corp traded under MDNA on the Toronto Stock Exchange (TSX).

Trading volume was 121,811 on 324 total trades. On average, Medicenna Therapeutics Corp has traded 105,169 shares over 5 days and 134,233 year-to-date.

Trading across the entire TSX saw 2,457 price advancers against 2,705 declines and 128 unchanged.

During the prior 52 weeks, MDNA.TO has traded as high as $2.89 (May 08,2024) and low as $0.22 (November 01,2023). Moreover, in the last 12 months, Medicenna Therapeutics Corp's shares have risen 159.41 percent, while they have risen 523.81% year-to-date.

Following today's trading, Medicenna Therapeutics Corp has a market capitalization of $210.88 million on a float of 69,637 shares outstanding. Its annual EPS is $-0.23.

Medicenna Therapeutics Corp is a TSX Biotechnology company headquartered in Toronto, CAN.

Currently, Medicenna Therapeutics Corp has an average recommendation of "Strong Buy" based on 2.00 analysts according to Zacks. Currently, there are 2 buy ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..